Iclepertin
- Generic Name
- Iclepertin
A Study in Healthy People to Test Whether Iclepertin Has an Effect on Cardiac Safety
- Conditions
- Healthy
- Interventions
- First Posted Date
- 2023-10-06
- Last Posted Date
- 2024-07-09
- Lead Sponsor
- Boehringer Ingelheim
- Target Recruit Count
- 56
- Registration Number
- NCT06070597
- Locations
- 🇩🇪
CRS Clinical Research Services Mannheim GmbH, Mannheim, Germany
A Study in Healthy Men to Test Whether Bosentan Influences the Amount of BI 425809 in the Blood
- First Posted Date
- 2023-02-13
- Last Posted Date
- 2023-06-06
- Lead Sponsor
- Boehringer Ingelheim
- Target Recruit Count
- 14
- Registration Number
- NCT05723874
- Locations
- 🇩🇪
Humanpharmakologisches Zentrum Biberach, Biberach, Germany
A Study to Test How Iclepertin is Taken up in the Blood of People With and Without Kidney Problems
- First Posted Date
- 2023-02-08
- Last Posted Date
- 2023-11-18
- Lead Sponsor
- Boehringer Ingelheim
- Target Recruit Count
- 36
- Registration Number
- NCT05718843
- Locations
- 🇩🇪
CRS Clinical Research Services Kiel GmbH, Kiel, Germany
A Study in Healthy Women to Test Whether BI 425809 Influences the Amount of a Contraceptive in the Blood
- First Posted Date
- 2022-11-14
- Last Posted Date
- 2023-10-19
- Lead Sponsor
- Boehringer Ingelheim
- Target Recruit Count
- 19
- Registration Number
- NCT05613777
- Locations
- 🇩🇪
CRS Clinical Research Services Mannheim GmbH, Mannheim, Germany
A Study in Healthy People to Test How BI 425809 is Taken up in the Body When Taken With or Without Food
- First Posted Date
- 2022-04-26
- Last Posted Date
- 2023-01-04
- Lead Sponsor
- Boehringer Ingelheim
- Target Recruit Count
- 16
- Registration Number
- NCT05347004
- Locations
- 🇩🇪
Humanpharmakologisches Zentrum Biberach, Biberach, Germany
A Study in Healthy Men to Test Whether BI 425809 Influences the Amount of Midazolam in the Blood
- First Posted Date
- 2022-02-28
- Last Posted Date
- 2022-06-03
- Lead Sponsor
- Boehringer Ingelheim
- Target Recruit Count
- 15
- Registration Number
- NCT05258110
- Locations
- 🇩🇪
Humanpharmakologisches Zentrum Biberach, Biberach, Germany
A Study to Test Long-term Safety of Iclepertin in People With Schizophrenia Who Took Part in a Previous CONNEX Study
- First Posted Date
- 2022-01-27
- Last Posted Date
- 2025-04-27
- Lead Sponsor
- Boehringer Ingelheim
- Target Recruit Count
- 1362
- Registration Number
- NCT05211947
- Locations
- 🇬🇷
AX Mental Health Clinic, Heraclion, Greece
🇯🇵Hokuriku Hospital, Toyama, Nanto, Japan
🇯🇵Yamaguchi University Hospital, Yamaguchi, Ube, Japan
A Study in Healthy Men to Test How Fluconazole Influences the Amount of BI 425809 in the Blood
- First Posted Date
- 2021-10-13
- Last Posted Date
- 2022-01-12
- Lead Sponsor
- Boehringer Ingelheim
- Target Recruit Count
- 15
- Registration Number
- NCT05076409
- Locations
- 🇩🇪
Humanpharmakologisches Zentrum Biberach, Biberach, Germany
CONNEX-3: A Study to Test Whether Iclepertin Improves Learning and Memory in People With Schizophrenia
- First Posted Date
- 2021-04-27
- Last Posted Date
- 2025-01-09
- Lead Sponsor
- Boehringer Ingelheim
- Target Recruit Count
- 609
- Registration Number
- NCT04860830
- Locations
- 🇺🇸
Sunwise Clinical Research-Walnut Creek-70166, Walnut Creek, California, United States
🇺🇸Synexus Clinical Research-Atlanta-67262, Atlanta, Georgia, United States
🇺🇸Hassman Research Institute-Berlin-60540, Berlin, New Jersey, United States
Clinical Trial of Iclepertin Effect on Cognition and Functional Capacity in Schizophrenia (CONNEX-2)
- First Posted Date
- 2021-04-15
- Last Posted Date
- 2024-12-24
- Lead Sponsor
- Boehringer Ingelheim
- Target Recruit Count
- 611
- Registration Number
- NCT04846881
- Locations
- 🇺🇸
Research in Miami Inc, Hialeah, Florida, United States
🇺🇸Salem VA Medical Center, Salem, Virginia, United States
🇪🇸Benito Menni Complejo Asistencial en Salud Mental, Sant Boi de Llobregat, Spain
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.